- Investing Ideas
- U.S. Pharmaceuticals & Biotech Nano Cap Stocks
U.S. Pharmaceuticals & Biotech Nano Cap Stocks
Results
18
Stocks with a market cap under US$50M.
18 companies
RenovoRx
Market Cap: US$41.1m
A clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$0.95
7D
7.0%
1Y
-30.9%
BioXcel Therapeutics
Market Cap: US$38.9m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$1.31
7D
10.1%
1Y
-36.1%
Grace Therapeutics
Market Cap: US$38.9m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.33
7D
5.0%
1Y
-21.3%
Actinium Pharmaceuticals
Market Cap: US$32.0m
Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.
ATNM
US$1.01
7D
-1.0%
1Y
-38.8%
Bioqual
Market Cap: US$29.1m
Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
BIOQ
US$32.50
7D
0%
1Y
n/a
Dyadic International
Market Cap: US$26.6m
A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
DYAI
US$0.73
7D
-6.5%
1Y
-26.5%
MDxHealth
Market Cap: US$26.4m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$0.47
7D
-16.4%
1Y
-78.9%
MariMed
Market Cap: US$26.0m
Engages in cultivation, production, and selling of branded cannabis products in the United States.
MRMD
US$0.07
7D
3.0%
1Y
-0.4%
TherapeuticsMD
Market Cap: US$23.1m
Operates as a pharmaceutical royalty company in the United States and internationally.
TXMD
US$2.01
7D
-11.5%
1Y
68.9%
Cellectar Biosciences
Market Cap: US$19.9m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$2.49
7D
-10.8%
1Y
-66.3%
Bio Essence
Market Cap: US$14.5m
Engages in manufacturing and distributing health supplement products.
BIOE
US$0.27
7D
48.6%
1Y
145.7%
Jasper Therapeutics
Market Cap: US$13.7m
A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
JSPR
US$0.49
7D
4.1%
1Y
-91.2%
Biofrontera
Market Cap: US$13.2m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$1.00
7D
1.9%
1Y
60.2%
Pharma-Bio Serv
Market Cap: US$12.9m
Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.56
7D
0%
1Y
-5.8%
Traws Pharma
Market Cap: US$12.7m
A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.
TRAW
US$0.86
7D
7.8%
1Y
-39.4%
CordovaCann
Market Cap: US$4.1m
Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.
LVRL.F
US$0.037
7D
14.8%
1Y
-6.8%
Sunset Island Group
Market Cap: US$34.4k
Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.
SIGO
US$0.0001
7D
0%
1Y
0%
FinCanna Capital
Market Cap: US$998.0
Does not have significant operations.
FNNZ.F
US$0.000001
7D
0%
1Y
-99.9%